Skip to main content
Journal of Microbiology and Biotechnology logoLink to Journal of Microbiology and Biotechnology
. 2022 Dec 19;33(2):180–187. doi: 10.4014/jmb.2210.10039

The Interkingdom Interaction with Staphylococcus Influences the Antifungal Susceptibility of the Cutaneous Fungus Malassezia

Juan Yang 1, Sungmin Park 1, Hyun Ju Kim 1, Sang Jun Lee 1, Won Hee Jung 1,*
PMCID: PMC9998211  PMID: 36575858

Abstract

The skin is a dynamic ecosystem on which diverse microbes reside. The interkingdom interaction between microbial species in the skin microbiota is thought to influence the health and disease of the skin although the roles of the intra- and interkingdom interactions remain to be elucidated. In this context, the interactions between Malassezia and Staphylococcus, the most dominant microorganisms in the skin microbiota, have gained attention. This study investigated how the interaction between Malassezia and Staphylococcus affected the antifungal susceptibility of the fungus to the azole antifungal drug ketoconazole. The susceptibility was significantly decreased when Malassezia was co-cultured with Staphylococcus. We found that acidification of the environment by organic acids produced by Staphylococcus influenced the decrease of the ketoconazole susceptibility of M. restricta in the co-culturing condition. Furthermore, our data demonstrated that the significant increased ergosterol content and cell membrane and wall thickness of the M. restricta cells grown in the acidic environment may be the main cause of the altered azole susceptibility of the fungus. Overall, our study suggests that the interaction between Malassezia and Staphylococcus influences the antifungal susceptibility of the fungus and that pH has a critical role in the polymicrobial interaction in the skin environment.

Keywords: Antifungal drug, co-culture, Malassezia, pH, Staphylococcus

Introduction

Analysis of the microbial community in the human body has revealed that fungi reside with other microbes, such as bacteria, protists, and viruses, within the community. This observation has led to several studies investigating the intra- or inter-kingdom interactions between microbial members influencing skin health and diseases [1-3]. For example, Pseudomonas aeruginosa and Aspergillus fumigatus often share the host niche, such as the airways of cystic fibrosis patients, and the interkingdom between the microorganisms is likely to occur within the same ecological site. In this scenario, P. aeruginosa produces metabolites, such as quorum sensing molecules and siderophores, that possess antifungal activity [4]. Furthermore, studies have reported the effect of bacteria on the antifungal susceptibility of pathogenic fungi. The interaction between Staphylococcus epidermidis and Candida albicans, co-colonizers of the skin, has also been investigated, especially in a mixed biofilm format. Fluconazole diffusion was retained, but no difference in susceptibility of C. albicans to the drug was observed in polymicrobial biofilms [5]. A direct influence of secreted enzymes, such as proteinase, from the major skin-associated fungus Malassezia on the biofilm formation of Staphylococcus aureus, a noteworthy skin opportunistic bacterial pathogen, was also demonstrated experimentally [6].

Malassezia is a commensal fungus found on the skin surfaces of warm-blooded animals, including humans, and comprised of 18 species [7-9]. Several studies based on amplicon sequencing and metagenome analysis demonstrated that Malassezia is the most dominant genus in the human skin. This fungus has been associated with various skin diseases, such as seborrheic dermatitis, dandruff, and atopic dermatitis [10, 11]. However, the roles of Malassezia in the skin must still be elucidated. Ketoconazole is an imidazole derivative and the most commonly used azole antifungal drug to treat Malassezia-associated skin diseases [12-14]. The mechanism of ketoconazole’s action against pathogenic fungi includes inhibiting 14α-lanosterol demethylase, which is encoded by ERG11, and converting lanosterol to ergosterol in the ergosterol biosynthesis pathway for fungal membrane synthesis; this results in the accumulation of toxic sterols causing increased membrane stress and growth arrest [15, 16]. Although the effectiveness of ketoconazole is well established, studies have reported that several fungal strains, including Malassezia, that have been isolated from clinical specimens were resistant to the drug [17-19]. In general, increased drug efflux, modification of the ergosterol biosynthetic pathway, and drug-targeting enzymes, such as mutation or overexpression of ERG11, are the primary cause of azole resistance [20]. Moreover, mutations in other genes in the ergosterol biosynthetic pathway, such as the ERG2, ERG3, ERG5, and ERG24 genes found in various fungal pathogens, have been associated with azole drug resistance [21, 22].

In this study, we investigated how the presence of Staphylococcus influenced the ketoconazole susceptibility of Malassezia fungi, particularly M. restricta. The interkingdom interaction between M. restricta and S. aureus or S. epidermidis was focused, and the antifungal susceptibility of the fungus against ketoconazole in the presence or absence of bacterial cells was determined. Altered ketoconazole susceptibility of M. restricta was observed when the fungal cells were cultured in the presence of S. aureus and S. epidermidis. To understand the mechanism behind this interkingdom interaction, we biochemically and genetically analyzed how Staphylococcus affects the antifungal susceptibility of M. restricta.

Materials and Methods

Strains and Growth Conditions

M. restricta KCTC 27527 [23], S. aureus NCTC 8325-4, and S. epidermidis KCTC 13172 were obtained from the Korean Collection for Type Cultures (KCTC, Korea) for this study. M. restricta KCTC 27527 was maintained in Leeming and Notman agar (LNA; 0.8% bile salt, 0.5% glucose, 0.1% glycerol, 1% peptone, 0.01% yeast extract, 0.05% glycerol monostearate, 1.2% agar, 0.05% Tween 60, and 0.5% whole fat cow milk) medium or modified Dixon medium (mDixon; 3.6% malt extract, 0.6% peptone, 2% bile salt, 1% Tween 40, 0.2% glycerol, and 0.2%oleic acid) [24, 25]. The mDixon media was prepared and adjusted to pH 5.0 or 6.5 with 5.8 M HCl. The M. restricta cells were cultured at 34°C for 3 to 4 days. The Staphylococcus cells were grown in tryptic soy broth (TSB; 1.7% casein peptone, 0.3% soybean peptone, 0.25% glucose, 0.5% sodium chloride, 0.25% dipotassium phosphate, and 1.5% agar) at 37°C [26].

Antifungal Susceptibility Test

Antifungal susceptibility was determined by disk diffusion assay on solid media using the top agar plates prepared as described in a previous study with modification [27]. Briefly, mDixon with 0.5% agar containing 2×108 cells/ml of M. restricta and 1×104 CFU/ml of Staphylococcus cells were poured onto the solid mDixon medium (1.5% agar). After the medium was solidified, 8 mm paper disks containing different ketoconazole concentrations, as described subsequently, were placed on the top surface of the agar medium. The plates were incubated at 34°C for 3 days, and the diameter of the growth inhibition zone was measured to determine M. restricta’s susceptibility to ketoconazole susceptibility.

Analysis of Organic Acids

The concentrations of organic acids in the co-culture medium were determined by high-performance liquid chromatography (Agilent 1100 Series HPLC system; Agilent Technologies, Inc., USA) with a refractive index (RI) detector (Waters 410 RI monitor, Waters Corp., USA) using an Aminex HPX-87H column (300 × 7.8 mm, BioRad Laboratories, Inc., USA) as described in a previous study [28]. After centrifugation of the co-culture broth, the supernatant was passed through a syringe filter (pore size of 0.22 μm). The column was isocratically eluted at 47°C with a flow rate of 0.5 ml min–1 using 0.01 N H2SO4 as the mobile phase.

Determination of the Ergosterol Contents

Gas chromatography-mass spectrometry (GC-MS) analysis was performed to determine the ergosterol contents in the fungal cells cultured at different pH as described in a previous study [29]. Briefly, M. restricta KCTC 27527 cells were cultured in 20 ml mDixon media at 34°C and harvested by centrifugation at 3,500 g for 5 min. Cell pellets were suspended in 600 μl of chloroform-methanol (2:1, v/v). Glass beads (0.4 mm) were added, and the cell suspension was vortexed for 3 min followed by centrifugation at 2,000 g for 15 min. The supernatant was transferred to a new tube and a 0.2 volume of 0.9% NaCl was added, vortexed for 1 min, and centrifuged. The lower phase was transferred to a new tube, then dried and dissolved in chloroform. The GC-MS analysis of the ergosterol content was performed on an Aligent DB-17 column (60 m, 0.32 mm, 0.5 μm film thickness; Agilent Technologies Inc., ) with a GERSTEL multi-purpose sampler MPS fitted with 2L-XT solid phase microextraction (GERSTEL GmbH & Co. KG, Germany), and a 7890A (GC)/5975C (MSD) system (Agilent Technologies Inc.,). A 2 μl sample was injected in split mode at the split ratio of 10:1. The initial temperature of the GC was held at 100°C for 2 min. The temperature was increased to 200°C at the rate of 50°C/min and subsequently raised to 280°C at the rate of 10°C/min, after which it was maintained for 12 min. Ergosterol was detected using a selected ion monitoring mode with an electron ionization energy of 70 eV. The fragment ions at m/z 363 were used for ergosterol quantitation. Concentrations were normalized to the total protein concentration.

Transmission Electron Microscopy

Transmission electron microscopy (TEM) was performed as described in a previous study [30]. Briefly, M. restricta KCTC 27527 cells were cultured in mDixon medium, pH 6.5 or 5.0, at 34°C for 3 days. Cells were fixed with 2.5% glutaraldehyde in 0.1 M sodium phosphate buffer (PBS) (pH 7.4) at 4°C overnight, then washed for 5 min with 0.1 M PBS (pH 7.4) three times at room temperature. Cells were post-fixed with 1.0% osmium tetroxide in 0.1 M PBS (pH 7.4) at 4°C for 1 h, washed with distilled water three times at room temperature for 5 min, and stained with 0.5% uranyl acetate at 4°C overnight. After washing three times for 5 min in distilled water at room temperature, cells were gradually dehydrated with 30%, 50%, 70%, 80%, 90%, and 100% ethanol for 10 min each at room temperature, and finally washed with 100% ethanol twice. The cells were embedded with fresh Spurr’s resin at 4°C overnight, then subsequently for 3 h at room temperature, and polymerized at 70°C overnight. After polymerization, ultrathin (70-nm-thick) sections were prepared. The samples were mounted on a 200-mesh copper grid, stained with 2% uranyl acetate solution, and analyzed using a LIBRA 120 energy-filtering transmission electron microscope (EF-TEM; Carl Zeiss AG, Germany).

Determination of Intracellular Heme Contents

The fungal cells were cultured in mDixon media at 34°C. Cells were harvested, then washed twice with PBS (pH 7.4), and suspended in lysis buffer containing 10 mM Tris-HCl (pH 8.0) and 150 mM sodium chloride. The fungal cells were lysed using 0.4 mm glass beads and a Beadbeater homogenizer (BioSpec Products, Inc., USA), followed by centrifugation at 13,000 rpm for 3 min at 4°C. The supernatant was used to measure the heme level with a colorimetric analysis using the BioVision hemin assay kit (BioVision Inc., USA) according to the manufacturer’s instructions. The heme concentrations were normalized with the total protein.

Results

Malassezia Co-Cultured with Staphylococcus Showed Reduced Susceptibility to Ketoconazole

Among several Malassezia species, M. restricta was used in our study because the species is the most predominant on human skin [31]. We first tested the growth of M. restricta and the Staphylococcus species, S. aureus and S. epidermidis, in either fungal (mDixon) or bacterial (TSB) medium. While M. restricta did not grow in the TSB medium, likely due to a lack of sufficient lipid supplement, Staphylococcus strains grew well in both media (Fig. S1). Therefore, mDixon medium was selected as a standard medium throughout the study. Next, we tested if the interkingdom interaction between M. restricta and S. aureus or S. epidermidis influenced the susceptibility of the fungus to the azole antifungal drug ketoconazole. Disk diffusion assays were carried out, and the results showed that the zone of inhibition was significantly reduced on the culture plate where M. restricta and S. aureus or S. epidermidis were co-cultured compared to the M. restricta axenic culture (Fig. 1). These results indicated that interkingdom interaction between M. restricta and S. aureus or S. epidermidis influenced the susceptibility of the fungal cells to ketoconazole.

Fig. 1. The results of the agar disk diffusion assay.

Fig. 1

(A) Images show different concentrations (0.5 or 2.0 μg per disk) of ketoconazole against M. restricta or M. restricta co-cultured with S. aureus or S. epidermidis. (B) Diameters of the zone of inhibition on each plate containing different concentrations of ketoconazole were measured and displayed on the y-axis. Four independent experiments were performed, and the values represent averages with standard deviations (*p < 0.05; **p < 0.01).

Staphylococcus Lowered the pH of the Co-Culture Medium by Producing Organic Acids

Next, we investigated the interkingdom interactions between Malassezia and Staphylococcus that caused the reduced antifungal susceptibility of the fungus. The change in the co-culture medium’s pH was of particular interest; environmental pH has been reported to alter the antifungal susceptibility of pathogenic fungi, such as C. albicans [32]. Furthermore, a study suggested that S. epidermidis increased the production of organic acids, such as lactic acid, decreasing the pH in mediums containing certain carbohydrates, such as oats [33]. Therefore, the pH changes of the medium’s supernatant were determined when M. restricta and S. aureus or S. epidermidis were co-cultured. While no significant pH change in the M. restricta axenic culture medium was observed, a significantly decreased pH (~ 4.7) was observed in the co-culture medium containing M. restricta and S. aureus or M. restricta and S. epidermidis (Fig. 2A). Furthermore, pH was decreased in the co-culture medium with different S. aureus and S. epidermidis strains, suggesting alteration of the pH is a general phenomenon independent of the Staphylococcus species and strains (Fig. 2A). However, we noticed that the pH of the co-culture medium was lowered, and the pH of the axenic cultures of either S. aureus or S. epidermidis were reduced significantly; this indicated that staphylococcal cells altered the pH of the medium no matter if M. restricta was present or not (Fig. 2A).

Fig. 2. Reduction of pH in the culture medium and production of organic acids by Staphylococcus.

Fig. 2

(A) pH of the medium of the M. restricta axenic culture or M. restricta co-cultured with S. aureus or S. epidermidis determined after 24 h incubation at 34°C. (B) Acetate or lactate production was determined in the medium of the M. restricta axenic culture or M. restricta co-culture with S. aureus NCTC 8325-4 or S. epidermidis KCTC 13172 after 24 h incubation at 34°C. (C) Acetate or lactate production was determined in the medium of the S. aureus NCTC 8325-4 or S. epidermidis KCTC 13172 axenic culture after 24 h incubation at 34°C. (D) The results of the agar disk diffusion assay. Images show different concentrations (0.5 or 2.0 μg per disk) of ketoconazole against M. restricta in different pH mediums. Three independent experiments were performed, and the values represent averages with standard deviations. Mala: M. restricta KCTC 27527; SAN: S. aureus NCTC 8325-4; SAU: S. aureus USA 300; SEK: S. epidermidis KCTC 13172; SEA: S. epidermidis ACTC 12228.

As previously mentioned, we reasoned that the organic acids produced by Staphylococcus may be the primary cause of the lowered pH values in the medium. Therefore, we determined the concentration of organic acids, such as acetate, lactate, and succinate, in the co-culture medium after 24 h of incubation. Among the organic acids, the concentrations of acetate and lactate increased markedly in the M. restricta and S. aureus co-culture medium by 14.6 and 2.4 mM, respectively. In the medium that M. restricta and S. epidermidis were co-cultured, acetate and lactate were found to be 26.5 and 2.6 mM, respectively (Fig. 2B).

Furthermore, acetate and lactate production levels were determined in the axenic culture of S. aureus and S. epidermidis to investigate if the increased organic acid concentrations were influenced by the presence of M. restricta in the co-culture medium. The concentration of acetate and lactate in the S. aureus and S. epidermidis axenic culture mediums were similar to that found in the co-culture medium; this suggested that the production of organic acids was solely from the bacterial cells’ metabolism and independent of the presence of Malassezia (Fig. 2C).

Altered Ergosterol Content, Cell Membrane and Wall Thickness, and Intracellular Heme Levels May Contribute to Decreased Ketoconazole Susceptibility of Malassezia Cultured in an Acidic pH

Subsequently, we investigated how pH of the medium influenced the susceptibility of M. restricta against ketoconazole. M. restricta was grown in the medium with a different pH of 5.0 or 6.5, and the cells’ susceptibility to ketoconazole was compared. The results showed that the ketoconazole susceptibility of the M. restricta cells grown at pH 5.0 was significantly reduced compared to those grown at pH 6.5. The results confirmed that pH is a critical environmental factor affecting the susceptibility of M. restricta against the azole antifungal drug ketoconazole (Fig. 2D).

Several mechanisms are responsible for altering the susceptibility of fungi to azole antifungal drugs; increased ergosterol content is one of them. Indeed, several clinically isolated azole-resistant pathogenic fungi displayed higher ergosterol contents than azole-susceptible strains [34-36]. In this context, we compared the ergosterol contents of M. restricta cells grown at pH 5.0 with those grown at pH 6.5. The results showed that the M. restricta cells grown at pH 5.0 possessed higher ergosterol content than those grown at pH 6.5; this may contribute to the decreased ketoconazole susceptibility of the M. restricta at an acidic pH (Fig. 3A). In addition to measuring the ergosterol contents, we used TEM to observe the M. restricta cells’ morphology, cell membrane and wall structure of the cells grown at pH 5.0 and pH 6.5. While no morphological difference was found between M. restricta cells grown in the different pH mediums, a significant increase in the cell membrane and wall thickness was observed in the cells grown at pH 5.0 compared with those grown at pH 6.5 (Figs. 3B and 3C).

Fig. 3. Ergosterol content and the cell membrane and wall thickness were influenced by pH.

Fig. 3

(A) The ergosterol contents in the M. restricta cells cultured at different pH mediums were determined by GC-MS. The ergosterol contents were significantly increased in the fungal cells grown at pH 5.0. Four independent experiments were performed, and the values represent averages with standard deviations (*p < 0.05). (B) The cell membrane and wall thickness of the M. restricta cells grown at different pH mediums were observed by TEM. (C) The cell membrane and wall thickness of 50 individual fungal cells grown at pH 5.0 and 6.5. The values represent averages with standard deviations (**p < 0.001).

Ergosterol biosynthesis has been reported to be influenced by iron availability in fungi. Previous studies have shown that iron depletion increased Aspergillus fumigatus and Cryptococcus neoformans’ fluconazole susceptibility [37-39]. Among the iron-containing metabolites, we were particularly interested in heme because of its involvement in antifungal susceptibility [40-42]. Therefore, we compared the intracellular heme levels in M. restricta grown at pH 5.0 with that of cells grown at pH 6.5. The results showed higher heme levels in the M. restricta cells cultured in the pH 5.0 medium than that in the pH 6.5 medium; this finding indicated that reduced heme contents might also contribute to the decreased ketoconazole susceptibility of M. restricta at an acidic pH (Fig. 4). Overall, our data suggested that M. restricta cells’ decreased ketoconazole susceptibility at acidic pH primarily caused by elevated ergosterol content, increased the intracellular heme levels and cell membrane and wall thickness; this implied that environmental pH is critical for M. restricta’s antifungal susceptibility and physiology.

Fig. 4. Heme levels in M. restricta were influenced by pH. M. restricta cells were cultured at pH 5.0 and 6.5 and the intracellular heme levels were determined.

Fig. 4

Three independent experiments were performed, and the values represented are averages with standard deviations. Statistical significance was calculated using the unpaired two-tailed t test. (*p < 0.05).

Discussion

This study provided evidence of the interkingdom interaction between Staphylococcus and Malassezia, predominant bacterial and fungal genera on the human skin, respectively, which influenced the fungus’ susceptibility to the antifungal drug ketoconazole. We demonstrated that the pH reduction mediated by S. aureus and S. epidermidis decreased M. restricta’s ketoconazole susceptibility. The influence of pH on the susceptibility of pathogenic fungi to azole antifungal drugs has been reported previously [43-45]. For example, clinically isolated C. albicans strains showed markedly reduced susceptibility to clotrimazole, miconazole, and fluconazole at pH 4.0 than at pH 7.0 [46]. Nevertheless, how pH affects the antifungal susceptibility of the fungi against azole antifungal drugs has not been fully elucidated, and only a few cellular mechanisms have been suggested.

Environmental pH influences the cytoplasmic and cellular organelles’ pH homeostasis and may therefore contribute to changes the susceptibility of a fungal cell to antifungal drugs. In particular, the proper regulation of vacuolar acidification has been reported to be closely linked to azole antifungal treatment in C. albicans. Specifically, fluconazole treatment has been demonstrated to disrupt vacuole acidification and trafficking, causing the depletion of ergosterol and deficiency in the vacuole ATPase (V-ATPase) function [47]. V-ATPase is essential in all eukaryotic cells, and Saccharomyces cerevisiae mutants lacking ERG24 exhibited notable growth defects in alkaline conditions while growing relatively well at an acidic pH [47, 48]. The mutant’s growth defects at an alkali pH supported that vacuole acidification is tightly connected with ergosterol synthesis [47]. Furthermore, the S. cerevisiae V-ATPase and the erg24 mutants grew relatively well at pH 4.3, suggesting that the fungal cells are more sensitive to the deficiency in vacuolar acidification and ergosterol synthesis in alkali than acidic growth conditions [47]. Therefore, we speculated that similar mechanisms might exist in Malassezia, and ergosterol synthesis and vacuole acidification in the Malassezia cells are relatively more vulnerable to azole antifungal drugs at alkali than acidic conditions.

The skin surface’s pH is one of the critical factors for the barrier function of the skin. The optimal pH range of the healthy skin surface typically lies between pH 4.1 and 5.8 (mean 4.9) [49]. Maintaining an acidic pH is contributed by filaggrin degradation pathway, free fatty acids, melanin-containing granules, and sodium-hydrogen exchanger 1 [49]. Maintenance of an acidic pH is also vital for the functions and roles of the stratum corneum, which forms the outermost layer of the skin and is composed of corneocytes filled mainly with keratin proteins and extracellular materials enriched with a lipid matrix [50]. The enzymes involved in synthesizing ceramide, the major lipid component of the stratum corneum, are most active in acidic conditions [51]. An acidic pH also represses the growth and pathogenesis of bacteria, including Staphylococcus species, in the skin’s environment [52]. In addition to endogenous mechanisms that contribute to the regulation of pH, microbial products, such as organic and fatty acids from skin microbiota, also contribute acid pH of the skin [53].

In this study, we found that S. aureus and S. epidermis produced acetate and lactate, reducing the pH of the growth medium; in turn, this contributed to changes in Malassezia’s antifungal susceptibility against ketoconazole. Several in vitro studies suggested the metabolic characteristics of S. aureus in aerobic or anaerobic conditions and have monitored and measured the production of the organic acids to interpret the metabolic remodeling of the bacteria during infections and in different host niches [33, 54]. However, we are not sure if Staphylococcus produces organic acids in vivo in relatively large amounts and if this contributes to the acidic pH of the skin. Despite this, the results of this study suggest that the pH of the skin surface affects the outcomes of antifungal treatment.

Our study revealed that intracellular heme levels were increased in M. restricta grown in a medium at pH 5.0 compared with a medium at pH 6.5; this may contribute to the decreased ketoconazole susceptibility of the fungus. Intracellular heme content is essential in iron metabolism and homeostasis, and an association between iron metabolism and susceptibility to azole antifungal drugs has been observed in several fungal pathogens. For example, increased fluconazole susceptibilities were found in C. neoformans and A. fumigatus grown under iron-limited conditions [38, 39]. Moreover, in iron-depleted C. albicans cells, downregulation of ERG11 and reduced ergosterol synthesis were demonstrated [37]. In addition, heme is required for the activity of the damage response protein Dap1, which regulates the stability of the Erg11 protein in S. cerevisiae and C. glabrata [40, 55]. This observation supports the connection between heme and iron metabolism in ergosterol synthesis and the susceptibility of the fungal cells to the drugs that inhibit the ergosterol synthesis pathway. In this study, we demonstrated that a conserved connection between heme and iron metabolism and azole antifungal drugs exists in M. restricta; the fungus increased intracellular heme levels at an acidic pH, which may contribute to increased ergosterol synthesis.

Overall, the results of our study suggested that in interactions between Staphylococcus and M. restricta, the bacteria reduce the environmental pH by secreting the organic acids acetate and lactate. Reduction of environmental pH altered intracellular heme and ergosterol contents, and increased cell wall and membrane thickness in M. restricta, which likely caused decreased ketoconazole susceptibility of the fungus.

Supplemental Materials

jmb-33-2-180-supple.pdf (222.4KB, pdf)

Supplementary data for this paper are available on-line only at http://jmb.or.kr.

Acknowledgments

This research was supported by the Chung-Ang University Graduate Research Scholarship in 2022, and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning, 2021M3A9I4021431 and 2022R1F1A1065306.

Footnotes

Conflict of Interest

The authors have no financial conflicts of interest to declare.

REFERENCES

  • 1.Ramsey MM, Freire MO, Gabrilska RA, Rumbaugh KP, Lemon KP. Staphylococcus aureus shifts toward commensalism in response to Corynebacterium species. Front. Microbiol. 2016;7:1230. doi: 10.3389/fmicb.2016.01230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kim HJ, Oh HN, Park T, Kim H, Lee HG, An S, et al. Aged related human skin microbiome and mycobiome in Korean women. Sci. Rep. 2022;12:2351. doi: 10.1038/s41598-022-06189-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Tao R, Li R, Wang R. Dysbiosis of skin mycobiome in atopic dermatitis. Mycoses. 2022;65:285–293. doi: 10.1111/myc.13402. [DOI] [PubMed] [Google Scholar]
  • 4.Chatterjee P, Sass G, Swietnicki W, Stevens DA. Review of potential Pseudomonas weaponry, relevant to the Pseudomonas-Aspergillus interplay, for the mycology community. J. Fungi (Basel). 2020;6:81. doi: 10.3390/jof6020081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Al-Fattani MA, Douglas LJ. Penetration of Candida biofilms by antifungal agents. Antimicrob. Agents Chemother. 2004;48:3291–3297. doi: 10.1128/AAC.48.9.3291-3297.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Li H, Goh BN, Teh WK, Jiang Z, Goh JPZ, Goh A, et al. Skin commensal Malassezia globosa secreted protease attenuates Staphylococcus aureus biofilm formation. J. Invest. Dermatol. 2018;138:1137–1145. doi: 10.1016/j.jid.2017.11.034. [DOI] [PubMed] [Google Scholar]
  • 7.Guého E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie Van Leeuwenhoek. 1996;69:337–355. doi: 10.1007/BF00399623. [DOI] [PubMed] [Google Scholar]
  • 8.Cho YJ, Kim T, Croll D, Park M, Kim D, Keum HL, et al. Genome of Malassezia arunalokei and its distribution on facial skin. Microbiol. Spectr. 2022;10:e0050622. doi: 10.1128/spectrum.00506-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Honnavar P, Prasad GS, Ghosh A, Dogra S, Handa S, Rudramurthy SM. Malassezia arunalokei sp. nov., a novel yeast species isolated from seborrheic dermatitis patients and healthy individuals from India. J. Clin. Microbiol. 2016;54:1826–1834. doi: 10.1128/JCM.00683-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Theelen B, Cafarchia C, Gaitanis G, Bassukas ID, Boekhout T, Dawson TL., Jr Malassezia ecology, pathophysiology, and treatment. Med. Mycol. 2018;56:S10–S25. doi: 10.1093/mmy/myx134. [DOI] [PubMed] [Google Scholar]
  • 11.Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL., Jr Skin diseases associated with Malassezia species. J. Am. Acad. Dermatol. 2004;51:785–798. doi: 10.1016/j.jaad.2003.12.034. [DOI] [PubMed] [Google Scholar]
  • 12.Piérard-Franchimont C, Piérard GE, Arrese JE, De Doncker P. Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments. Dermatology. 2001;202:171–176. doi: 10.1159/000051628. [DOI] [PubMed] [Google Scholar]
  • 13.Goularte-Silva V, Paulino LC. Ketoconazole beyond antifungal activity: Bioinformatics-based hypothesis on lipid metabolism in dandruff and seborrheic dermatitis. Exp. Dermatol. 2022;31:821–822. doi: 10.1111/exd.14505. [DOI] [PubMed] [Google Scholar]
  • 14.Levine HB, Cobb JM. Oral therapy for experimental coccidioidomycosis with R41 400 (ketoconazole), a new imidazole. Am. Rev. Respir. Dis. 1978;118:715–721. doi: 10.1164/arrd.1978.118.4.715. [DOI] [PubMed] [Google Scholar]
  • 15.Prasad R, Shah AH, Rawal MK. Antifungals: Mechanism of action and drug resistance. Adv. Exp. Med. Biol. 2016;892:327–349. doi: 10.1007/978-3-319-25304-6_14. [DOI] [PubMed] [Google Scholar]
  • 16.Kelly SL, Lamb DC, Corran AJ, Baldwin BC, Kelly DE. Mode of action and resistance to azole antifungals associated with the formation of 14α-methylergosta-8, 24 (28)-dien-3β, 6α-diol. Biochem. Biophys. Res. Commun. 1995;207:910–915. doi: 10.1006/bbrc.1995.1272. [DOI] [PubMed] [Google Scholar]
  • 17.Park M, Cho YJ, Lee YW, Jung WH. Genomic multiplication and drug efflux influence ketoconazole resistance in Malassezia restricta. Front. Cell Infect. Microbiol. 2020;10:191. doi: 10.3389/fcimb.2020.00191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kim M, Cho Y-J, Park M, Choi Y, Hwang SY, Jung WH. Genomic tandem quadruplication is associated with ketoconazole resistance in Malassezia pachydermatis. J. Microbiol. Biotechnol. 2018;28:1937–1945. doi: 10.4014/jmb.1810.10019. [DOI] [PubMed] [Google Scholar]
  • 19.Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob. Agents Chemother. 2005;49:668–679. doi: 10.1128/AAC.49.2.668-679.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Cowen LE, Sanglard D, Howard SJ, Rogers PD, Perlin DS. Mechanisms of antifungal drug resistance. Cold Spring Harb. Perspect. Med. 2015;5:a019752. doi: 10.1101/cshperspect.a019752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Geber A, Hitchcock CA, Swartz JE, Pullen FS, Marsden KE, Kwon-Chung KJ, et al. Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob. Agents and Chemother. 1995;39:2708–2717. doi: 10.1128/AAC.39.12.2708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Eddouzi J, Parker JE, Vale-Silva LA, Coste A, Ischer F, Kelly S, et al. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals. Antimicrob. Agents Chemother. 2013;57:3182–3193. doi: 10.1128/AAC.00555-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Park M, Cho YJ, Lee YW, Jung WH. Whole genome sequencing analysis of the cutaneous pathogenic yeast Malassezia restricta and identification of the major lipase expressed on the scalp of patients with dandruff. Mycoses. 2017;60:188–197. doi: 10.1111/myc.12586. [DOI] [PubMed] [Google Scholar]
  • 24.Leeming JP, Notman FH. Improved methods for isolation and enumeration of Malassezia furfur from human skin. J. Clin. Microbiol. 1987;25:2017–2019. doi: 10.1128/jcm.25.10.2017-2019.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Midgley G. The diversity of Pityrosporum (Malassezia) yeasts in vivo and in vitro. Mycopathologia. 1989;106:143–153. doi: 10.1007/BF00443055. [DOI] [PubMed] [Google Scholar]
  • 26.Doyle JE, Mehrhof WH, Ernst RR. Limitations of thioglycolate broth as a sterility test medium for materials exposed to gaseous ethylene oxide. Appl. Microbiol. 1968;16:1742–1744. doi: 10.1128/am.16.11.1742-1744.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Piddock LJ. Techniques used for the determination of antimicrobial resistance and sensitivity in bacteria. Antimicrobial Agents Research Group. J. Appl. Bacteriol. 1990;68:307–318. doi: 10.1111/j.1365-2672.1990.tb02880.x. [DOI] [PubMed] [Google Scholar]
  • 28.Kim HJ, Jeong H, Lee SJ. Short-term adaptation modulates anaerobic metabolic flux to succinate by activating ExuT, a novel Dglucose transporter in Escherichia coli. Front. Microbiol. 2020;11:27. doi: 10.3389/fmicb.2020.00027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Varga M, Bartók T, Mesterházy A. Determination of ergosterol in Fusarium-infected wheat by liquid chromatographyatmospheric pressure photoionization mass spectrometry. J. Chromatogr. A. 2006;1103:278–283. doi: 10.1016/j.chroma.2005.11.051. [DOI] [PubMed] [Google Scholar]
  • 30.Park M, Cho YJ, Kim D, Yang CS, Lee SM, Dawson TL, Jr, et al. A novel virus alters gene expression and vacuolar morphology in Malassezia cells and induces a TLR3-mediated inflammatory immune response. mBio. 2020;11:e01521–20. doi: 10.1128/mBio.01521-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature. 2013;498:367–370. doi: 10.1038/nature12171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Danby CS, Boikov D, Rautemaa-Richardson R, Sobel JD. Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use. Antimicrob. Agents Chemother. 2012;56:1403–1406. doi: 10.1128/AAC.05025-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Liu-Walsh F, Tierney NK, Hauschild J, Rush AK, Masucci J, Leo GC, et al. Prebiotic colloidal oat supports the growth of cutaneous commensal bacteria including S. epidermidis and enhances the production of lactic acid. Clin. Cosmet. Investig. Dermatol. 2021;14:73–82. doi: 10.2147/CCID.S253386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.vanden Bossche H, Marichal P, Odds FC, Le Jeune L, Coene MC. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 1992;36:2602–2610. doi: 10.1128/AAC.36.12.2602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Khalaf RA, Fattouh N, Medvecky M, Hrabak J. Whole genome sequencing of a clinical drug resistant Candida albicans isolate reveals known and novel mutations in genes involved in resistance acquisition mechanisms. J. Med. Microbiol. 2021;70:001351. doi: 10.1099/jmm.0.001351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Jiang C, Dong D, Yu B, Cai G, Wang X, Ji Y, et al. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J. Antimicrob. Chemother. 2013;68:778–785. doi: 10.1093/jac/dks481. [DOI] [PubMed] [Google Scholar]
  • 37.Prasad T, Chandra A, Mukhopadhyay CK, Prasad R. Unexpected link between iron and drug resistance of Candida spp. Iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells. Antimicrob. Agents Chemother. 2006;50:3597–3606. doi: 10.1128/AAC.00653-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Zarember KA, Cruz AR, Huang CY, Gallin JI. Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob. Agents Chemother. 2009;53:2654–2656. doi: 10.1128/AAC.01547-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kim J, Cho YJ, Do E, Choi J, Hu G, Cadieux B, et al. A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs. Fungal Genet. Biol. 2012;49:955–966. doi: 10.1016/j.fgb.2012.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hosogaya N, Miyazaki T, Nagi M, Tanabe K, Minematsu A, Nagayoshi Y, et al. The heme-binding protein Dap1 links iron homeostasis to azole resistance via the P450 protein Erg11 in Candida glabrata. FEMS Yeast Res. 2013;13:411–421. doi: 10.1111/1567-1364.12043. [DOI] [PubMed] [Google Scholar]
  • 41.Craven RJ, Mallory JC, Hand RA. Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51. J. Biol. Chem. 2007;282:36543–36551. doi: 10.1074/jbc.M706770200. [DOI] [PubMed] [Google Scholar]
  • 42.Agarwal AK, Xu T, Jacob MR, Feng Q, Lorenz MC, Walker LA, et al. Role of heme in the antifungal activity of the azaoxoaporphine alkaloid sampangine. Eukaryot Cell. 2008;7:387–400. doi: 10.1128/EC.00323-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Rogers TE, Galgiani JN. Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo. Antimicrob. Agents Chemother. 1986;30:418–422. doi: 10.1128/AAC.30.3.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.McIntyre KA, Galgiani JN. In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy. Antimicrob. Agents Chemother. 1989;33:1095–1100. doi: 10.1128/AAC.33.7.1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Peng T, Galgiani JN. In vitro studies of a new antifungal triazole, D0870, against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrob. Agents Chemother. 1993;37:2126–2131. doi: 10.1128/AAC.37.10.2126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Liu W, Zhang X, Liu Z, Luo X. Impact of pH on the antifungal susceptibility of vaginal Candida albicans. Int. J. Gynaecol. Obstet. 2011;114:278–280. doi: 10.1016/j.ijgo.2011.03.016. [DOI] [PubMed] [Google Scholar]
  • 47.Zhang YQ, Gamarra S, Garcia-Effron G, Park S, Perlin DS, Rao R. Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs. PLoS Pathog. 2010;6:e1000939. doi: 10.1371/journal.ppat.1000939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Sambade M, Kane PM. The yeast vacuolar proton-translocating ATPase contains a subunit homologous to the Manduca sexta and bovine e subunits that is essential for function. J. Biol. Chem. 2004;279:17361–17365. doi: 10.1074/jbc.M314104200. [DOI] [PubMed] [Google Scholar]
  • 49.Proksch E. pH in nature, humans and skin. J. Dermatol. 2018;45:1044–1052. doi: 10.1111/1346-8138.14489. [DOI] [PubMed] [Google Scholar]
  • 50.Elias PM. Structure and function of the stratum corneum extracellular matrix. J. Invest. Dermatol. 2012;132:2131–2133. doi: 10.1038/jid.2012.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Jensen JM, Schütze S, Förl M, Krönke M, Proksch E. Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J. Clin. Invest. 1999;104:1761–1770. doi: 10.1172/JCI5307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Lund P, Tramonti A, De Biase D. Coping with low pH: molecular strategies in neutralophilic bacteria. FEMS Microbiol. Rev. 2014;38:1091–1125. doi: 10.1111/1574-6976.12076. [DOI] [PubMed] [Google Scholar]
  • 53.Costa FG, Horswill AR. Overcoming pH defenses on the skin to establish infections. PLoS Pathog. 2022;18:e1010512. doi: 10.1371/journal.ppat.1010512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Sun JL, Zhang SK, Chen JY, Han BZ. Metabolic profiling of Staphylococcus aureus cultivated under aerobic and anaerobic conditions with (1)H NMR-based nontargeted analysis. Can. J. Microbiol. 2012;58:709–718. doi: 10.1139/w2012-046. [DOI] [PubMed] [Google Scholar]
  • 55.Mallory JC, Crudden G, Johnson BL, Mo C, Pierson CA, Bard M, et al. Dap1p, a heme-binding protein that regulates the cytochrome P450 protein Erg11p/Cyp51p in Saccharomyces cerevisiae. Mol. Cell Biol. 2005;25:1669–1679. doi: 10.1128/MCB.25.5.1669-1679.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

jmb-33-2-180-supple.pdf (222.4KB, pdf)

Supplementary data for this paper are available on-line only at http://jmb.or.kr.


Articles from Journal of Microbiology and Biotechnology are provided here courtesy of Korean Society for Microbiology and Biotechnology

RESOURCES